BY VANESSA ALEXANDRA KJAER
-
Eli Lilly signs USD 1.84bn deal with Repertoire for new vaccines
The brand-new contract in between Eli Lilly and Repertoire might possibly get to USD 1.84 bn, which will certainly be made use of to establish injections versus autoimmune illness.
-
AstraZeneca signs billion-dollar deal with Hong Kong-based CSPC for new slimming drugs
The contract might possibly get to a complete worth of approximately USD 18.5 bn.
-
Eli Lilly signs USD 1.84bn deal with Repertoire for new vaccines
The brand-new arrangement in between Eli Lilly and Repertoire can possibly get to USD 1.84 bn, which will certainly be utilized to establish vaccinations versus autoimmune illness.
-
Eli Lilly signs deal with German company worth up to USD 1.12bn
German business Seamless Therapy gets a considerable resources shot from Eli Lilly.s
-
Analysts urge caution despite positive reception of Novo Nordisk’s Wegovy pill in the US
Prescription numbers go beyond previous launches, yet experts warn it’s prematurely to call it a pattern.
-
Novo Nordisk sued in the US for hindering competition for diabetes drug
The US distributor J. M. Smith Corp. is demanding repayment and compensation from Novo Nordisk.
-
The most useful AI tool might already be in your browser
One of the most transformative AI device for online marketers could be the peaceful aide constructed right into your internet browser, providing instantaneous context without damag…
-
Amgen acquires British Dark Blue Therapeutics for USD 840m
Amgen enhances cancer cells study with procurement of Dark Blue Rehabs.
-
Weight loss drugs lose effectiveness after two years
Research reveals long-lasting techniques are required to stay clear of weight gain after drug ends.
-
GSK hepatitis B drug shows promising trial results
GSK’s therapy can enhance yearly incomes by numerous billion extra pounds.
